Study Finds Possible Treatment to Prevent TMPRSS3 Hearing Loss
A new study has identified how electrical charges in the inner ear trigger TMPRSS3-related hearing loss—and found that a common drug may help prevent it.
A new study has identified how electrical charges in the inner ear trigger TMPRSS3-related hearing loss—and found that a common drug may help prevent it.
Marshall Chasin fondly remembers Jack Katz, PhD, known for his pioneering work on central auditory processing disorders and improving audiology through research and education. He has died at the age of 91.
A new study reveals that binaural pitch fusion, crucial for understanding speech in noisy environments, continues to develop later than thought in children, presenting new opportunities for treatment and intervention.
Amptify introduced a new curriculum that is designed to support individuals with unique auditory challenges.
In an article published on the ”Discover Magazine” website, author Sarah Katz challenges the view in the scientific community that deafness is a problem that needs to be cured, potentially by new CRISPR technology that could eliminate a TMC1 gene mutation.
Rinri Therapeutics has developed a minimally invasive surgical method that advances neural hearing loss treatment.
Sound Pharmaceuticals has completed a Phase 3 clinical trial for SPI-1005, a novel anti-inflammatory treatment for Meniere’s Disease, showing potential improvements in hearing loss and tinnitus.